Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazoloacridine and Carboplatin in Recurrent Glioma
NCT00005976Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2000
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pyrazoloacridine in glioma, sponsored by National Cancer Institute. Started May 2000; status: completed.
02
Drugs
pyrazoloacridine
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00005976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005976.